封面
市场调查报告书
商品编码
1372799

负压伤口治疗市场-2018-2028年全球产业规模、份额、趋势、机会和预测,按产品、伤口类型、最终用途、地区、竞争预测和机会细分,2018-2028F

Negative Pressure Wound Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Wound Type, By End-use, By Region, By Competition Forecast & Opportunities, 2018-2028F

出版日期: | 出版商: TechSci Research | 英文 170 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022年全球负压伤口治疗市场估值已达23.4亿美元,并有望大幅成长,预计到2028年复合年增长率(CAGR)为6.47%。全球负压伤口治疗(NPWT)市场涉及透过施加负压来促进伤口癒合和控制渗出物来治疗各种伤口和溃疡的医疗技术和产品。 NPWT 由于其在加速伤口癒合、降低感染风险和改善患者治疗效果方面的功效而在医疗保健领域引起了广泛关注。

主要市场驱动因素

人口老化

市场概况
预测期 2024-2028
2022 年市场规模 23.4亿美元
2028 年市场规模 33.9亿美元
2023-2028 年复合年增长率 6.47%
成长最快的细分市场 医院
最大的市场 北美洲

全球医疗保健格局正在经历转变,部分原因是人口老化。随着世界各地人们的寿命越来越长,他们的慢性健康状况也越来越普遍,导致对先进医疗的需求更大。负压伤口治疗 (NPWT) 是一种显着增长的治疗方法。世界人口正以前所未有的速度老化。据联合国称,到2050 年,全球60 岁及以上人口预计将达到21 亿,几乎是2017 年的两倍。这种人群变化意义重大,因为老化往往伴随着可能导致慢性伤口的健康问题,包括糖尿病、循环系统问题和压疮。老化是一个自然过程,但它也与慢性健康问题的可能性增加有关。随着年龄的增长,糖尿病、週边血管疾病和肥胖等慢性疾病变得更加普遍。这些情况可能会导致伤口癒合缓慢或不癒合,这通常很难处理。 NPWT 已成为有效处理这些复杂伤口的重要工具。老年患者经常出现复杂的伤口,需要专门护理。 NPWT 提供了一种非侵入性的先进伤口管理解决方案,可显着改善癒合过程。它能够去除多余的液体、降低感染风险并促进组织肉芽形成,这使其成为治疗老年患者的医疗保健专业人员的一个有吸引力的选择。治疗老年人口中的慢性伤口的费用可能会很高。延长住院时间、频繁门诊、併发症风险都会增加医疗支出。 NPWT 可以透过促进伤口更快癒合来帮助减轻经济负担,从而降低住院时间和整体护理成本。由于慢性伤口限制了活动能力和独立性,老年人口的生活品质常常下降。 NPWT 可以透过加速伤口闭合和减轻疼痛来提高这些患者的生活品质。因此,患者可以更快地恢復活动能力和独立性。

新兴市场

全球负压伤口治疗 (NPWT) 市场在多种因素的推动下取得了显着增长,包括医疗技术的进步和对 NPWT 益处的认识的提高。这一增长的一个值得注意的贡献者是新兴市场的蓬勃发展。这些地区的特点是经济快速发展和医疗基础设施不断扩大,拥有将 NPWT 市场推向新高度的巨大潜力。新兴市场通常位于发展中国家,其特征是经济成长强劲、医疗保健支出不断增加以及中产阶级人口不断增长。这些市场正在见证医疗保健服务的变革,先进医疗治疗和技术的取得管道不断改善。因此,它们为医疗保健相关行业(包括 NPWT 市场)提供了前景广阔的前景。新兴市场正经历糖尿病、肥胖症和心血管疾病等慢性病的激增。这些情况与伤口不癒合的风险较高有关,这使得 NPWT 成为伤口管理和加速癒合的重要工具。随着这些疾病盛行率的增加,对 NPWT 的需求也增加。在医疗保健支出增加、现代医疗实践的采用以及人口老化不断加剧等因素的推动下,新兴市场的外科手术数量不断增加。手术伤口通常受益于 NPWT,从而导致对该技术的更高需求。新兴市场正在大力投资扩大其医疗基础设施,包括建立现代化的医院和诊所。随着医疗机构数量的不断增加,采用 NPWT 技术的机会更大。随着新兴市场医疗保健素养的提高,医疗保健专业人员和患者都更加了解 NPWT 等先进伤口护理解决方案。这种意识的提高推动了需求和采用率。 NPWT 虽然最初被认为昂贵,但从长远来看可能是一种具有成本效益的解决方案,特别是在住院费用和术后护理费用可能很高的新兴市场。这种成本效益正在鼓励医疗保健提供者和政策制定者接受 NPWT。

慢性病增加

全球负压伤口治疗 (NPWT) 市场正在经历显着成长,而这项扩张背后的关键驱动因素之一是全球慢性病的惊人成长。这些疾病包括糖尿病、肥胖、心血管疾病等,通常会导致慢性伤口,需要 NPWT 等复杂的伤口护理解决方案。慢性病已在全球流行,构成了重大的公共卫生挑战。世界卫生组织 (WHO) 报告称,慢性病约占全球死亡人数的 71%,成为全球死亡的主要原因。这种令人震惊的趋势是由多种因素所驱动的,包括久坐的生活方式、不良的饮食选择、人口老化和遗传倾向。慢性疾病,特别是糖尿病和周围血管疾病,通常会导致慢性伤口。这些伤口癒合缓慢且容易出现併发症,例如感染和组织坏死。 NPWT 已成为有效管理这些伤口的宝贵工具。 NPWT 透过创造一个刺激血流、减少水肿和去除多余液体的受控环境来促进伤口癒合。对于慢性伤口患者,NPWT 可以显着加速癒合过程并改善整体结果。慢性伤口患者感染和其他併发症的风险较高,这可能导致住院时间延长和医疗费用增加。 NPWT 可以减轻这些风险,从长远来看是一种具有成本效益的解决方案。糖尿病患者特别容易出现足部溃疡,这是糖尿病的常见併发症。 NPWT 已证明其在治疗糖尿病足溃疡方面的有效性,糖尿病足溃疡因癒合缓慢且可能需要截肢而臭名昭着。随着受慢性病影响的人数持续增加,潜在的 NPWT 患者数量也不断增加。患者群体的扩大是市场成长的重要动力。

外科手术

全球负压伤口治疗(NPWT)市场一直在经历大幅成长,而这种扩张背后的驱动力之一是外科手术的持续发展。随着手术技术变得更加先进和广泛,对 NPWT 等创新伤口护理解决方案的需求不断增加。负压伤口治疗,也称为真空辅助闭合(VAC)疗法,是一种用于加速伤口癒合的复杂医疗方法。它涉及透过连接到专用敷料的真空帮浦向伤口施加受控负压。这个过程可以去除多余的液体,刺激血液流动,并促进健康组织的生长,从而改善伤口癒合效果。现代医学见证了复杂外科手术的激增,包括器官移植、重建手术和减肥手术。这些手术通常会导致较大的手术伤口,需要 NPWT 等专门的伤口护理解决方案才能实现最佳癒合。微创手术技术因其恢復时间短和疤痕最小而受到欢迎。然而,即使是这些手术也可能需要 NPWT 才能达到最佳癒合,特别是在切口较大或出现併发症的情况下。由于事故和不可预见的医疗事件,创伤和紧急手术呈上升趋势。 NPWT 可以成为紧急手术期间管理伤口护理的重要工具,从而降低併发症的风险。

主要市场挑战

初始成本高

NPWT 市场面临的主要挑战之一是与该技术相关的相对较高的初始成本。对于医疗机构来说,NPWT 所需的设备和消耗品可能非常昂贵,因此是一项重大投资。规模较小且资金不足的医疗机构可能会发现难以负担这些前期费用。

报销问题

NPWT 报销政策和做法在不同国家和地区之间可能存在很大差异。在某些地区,医疗保健提供者面临不一致的报销率或复杂的计费流程。这可能会产生不确定性并阻碍 NPWT 的采用。

技术壁垒

儘管 NPWT 技术已取得显着进步,但仍有改进的空间。需要更小、更便携的设备来改善患者的活动能力和舒适度。此外,确保 NPWT 系统对使用者友好并且能够被医疗保健专业人员在各种环境中有效使用是一个持续的挑战。

全球供应链中断

COVID-19 大流行凸显了全球供应链的脆弱性。 NPWT 依赖消耗品和设备的及时供应,供应链中断可能会影响患者护理。製造商和医疗机构需要确保强大的供应链来满足需求。

主要市场趋势

便携式和可穿戴设备

NPWT 市场最令人兴奋的发展之一是便携式和穿戴式装置的出现。传统的 NPWT 系统通常体积庞大,并且需要患者保持不动。然而,穿戴式 NPWT 装置提供了更高的移动性和舒适度,使患者能够在接受治疗的同时继续进行日常活动。这些紧凑、用户友好的设备有望彻底改变伤口护理并提高患者的依从性。

互联医疗生态系统

将 NPWT 系统整合到互联的医疗保健生态系统中是即将出现的另一个重要趋势。这些智慧型设备将使医疗保健提供者能够远端监控患者的进展,确保有效地进行治疗。即时资料收集和分析将增强决策能力,有可能降低併发症的风险并改善患者的治疗结果。

高级敷料材料

敷料材料的创新将在 NPWT 市场的未来中发挥关键作用。製造商不断研究开发能够更好地贴合伤口形状、增强液体管理并提高患者舒适度的新型材料。这些材料旨在使 NPWT 对于患者和医疗保健提供者更加有效和方便。

生物活性 NPWT 解决方案

生物活性 NPWT 解决方案旨在透过促进组织再生和减少发炎来加速伤口癒合。这些新一代疗法可能会结合生长因子、抗菌剂和其他生物活性物质,以增强伤口癒合过程。随着该领域研究的进展,生物活性 NPWT 可能成为治疗复杂伤口的标准方法。

细分市场洞察

产品洞察

2022 年,传统设备类别占据了最大的收入份额,这主要归因于其高成本和不断增长的采用率。这些系统需要住院,并且由于依赖重型罐子而对于家庭护理使用来说是不切实际的。这些设备的租赁选项预计将提高购买力有限的发展中国家的 NPWT 利用率。

伤口类型见解

根据伤口类型类别,压疮细分市场将在 2022 年成为全球负压伤口治疗市场的主导者,主要是因为所需的治疗持续时间延长。患有压疮的患者通常需要更长的住院时间,从而导致医疗费用增加。推动这一增长的另一个因素是其在治疗褥疮等与压力相关的伤口方面的新兴应用。

相反,糖尿病足溃疡领域预计在预测期内将经历最显着的复合年增长率,这主要是由于其在 NPWT 治疗方面取得的显着成功以及糖尿病的高盛行率。糖尿病足溃疡是最常见的慢性伤口形式,NPWT 在加速此类损伤的癒合过程中发挥关键作用。其他伤口类别包括动脉溃疡和手术伤口等。

区域洞察

2022 年,由于该地区医疗保健支出的增加和高度先进的医疗保健基础设施,北美地区占据了收入的最大部分。因此,无论是在医院环境中还是在家庭护理中,NPWT 设备的采用显着增加。同时,在亚太地区,预计未来几年复合年增长率可望实现。这项预测主要源于烧伤等创伤事件的不断增加,从而刺激了该地理区域对此类治疗的需求。

目录

第 1 章:产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章:研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章:执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章:客户之声

第 5 章:全球负压伤口治疗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品(常规 NPWT、一次性 NPWT)
    • 依伤口类型(糖尿病足溃疡、腿部静脉溃疡、压疮、烧伤、其他)
    • 依最终用途(医院、家庭护理、其他)
    • 按地区
    • 按公司划分 (2022)
  • 产品市场地图
    • 按产品分类
    • 按伤口类型
    • 按最终用途
    • 按地区

第 6 章:北美负压伤口治疗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品(常规 NPWT、一次性 NPWT)
    • 依伤口类型(糖尿病足溃疡、腿部静脉溃疡、压疮、烧伤、其他)
    • 依最终用途(医院、家庭护理、其他)
    • 按国家/地区
  • 北美:国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章:欧洲负压伤口治疗市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品(常规 NPWT、一次性 NPWT)
    • 依伤口类型(糖尿病足溃疡、腿部静脉溃疡、压疮、烧伤、其他)
    • 依最终用途(医院、家庭护理、其他)
    • 按国家/地区
  • 欧洲:国家分析
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙

第 8 章:亚太地区负压伤口治疗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品(常规 NPWT、一次性 NPWT)
    • 依伤口类型(糖尿病足溃疡、腿部静脉溃疡、压疮、烧伤、其他)
    • 依最终用途(医院、家庭护理、其他)
    • 按国家/地区
  • 亚太地区:国家分析
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国

第 9 章:南美洲负压伤口治疗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品(常规 NPWT、一次性 NPWT)
    • 依伤口类型(糖尿病足溃疡、腿部静脉溃疡、压疮、烧伤、其他)
    • 依最终用途(医院、家庭护理、其他)
    • 按国家/地区
  • 南美洲:国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章:中东和非洲负压伤口治疗市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按产品(常规 NPWT、一次性 NPWT)
    • 依伤口类型(糖尿病足溃疡、腿部静脉溃疡、压疮、烧伤、其他)
    • 依最终用途(医院、家庭护理、其他)
    • 按国家/地区
  • MEA:国家分析
    • 南非负压伤口治疗
    • 沙乌地阿拉伯负压伤口治疗
    • 阿联酋负压伤口治疗
    • 科威特负压伤口治疗

第 11 章:市场动态

  • 司机
  • 挑战

第 12 章:市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章:波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第14章:竞争格局

  • 商业概览
  • 产品供应
  • 最近的发展
  • 财务(据报导)
  • 主要人员
  • SWOT分析
    • Acelity LP Inc
    • Talley's Group Ltd
    • Smith & Nephew PLC
    • Devon Health Services Inc
    • Molnlycke Health Care AB
    • Medela AG
    • DeRoyal Industries Inc
    • ConvaTec Inc
    • Cardinal Health Inc
    • PAUL HARTMANN AG

第 15 章:策略建议

第 16 章:关于我们与免责声明

简介目录
Product Code: 16231

The Global Negative Pressure Wound Therapy Market has reached a valuation of USD 2.34 billion in 2022 and is poised for substantial growth, with an expected Compound Annual Growth Rate (CAGR) of 6.47% through 2028. The Global Negative Pressure Wound Therapy (NPWT) Market pertains to the medical technologies and products employed in the treatment of diverse wounds and ulcers by applying negative pressure to promote wound healing and manage exudate. NPWT has garnered significant attention in the healthcare sector due to its efficacy in expediting wound healing, lowering the risk of infection, and enhancing patient outcomes.

Key Market Drivers

Aging Population

Market Overview
Forecast Period2024-2028
Market Size 2022USD 2.34 Billion
Market Size 2028USD 3.39 Billion
CAGR 2023-20286.47%
Fastest Growing SegmentHospitals
Largest MarketNorth America

The global healthcare landscape is undergoing a transformation, driven in part by the aging population. As people worldwide are living longer, they are also experiencing an increased prevalence of chronic health conditions, leading to a greater demand for advanced medical treatments. One such treatment that has seen significant growth is Negative Pressure Wound Therapy (NPWT). The world's population is aging at an unprecedented rate. According to the United Nations, by 2050, the global population aged 60 and above is expected to reach 2.1 billion, nearly double what it was in 2017. This demographic shift is significant because aging is often accompanied by health issues that can lead to chronic wounds, including diabetes, circulatory problems, and pressure ulcers. Aging is a natural process, but it is also associated with an increased likelihood of chronic health conditions. Chronic diseases such as diabetes, peripheral vascular disease, and obesity become more prevalent with age. These conditions can lead to slow-healing or non-healing wounds, which are often challenging to manage. NPWT has emerged as a crucial tool in addressing these complex wounds effectively. Aging patients often present with complex wounds that require specialized care. NPWT provides a non-invasive and advanced wound management solution that can significantly improve the healing process. Its ability to remove excess fluid, reduce infection risk, and promote tissue granulation makes it an attractive option for healthcare professionals dealing with elderly patients. The cost of treating chronic wounds in aging populations can be substantial. Extended hospital stays, frequent outpatient visits, and the risk of complications all contribute to healthcare expenditures. NPWT can help reduce the economic burden by facilitating faster wound healing, thus lowering hospitalization durations and the overall cost of care. The elderly population often faces diminished quality of life due to chronic wounds that limit mobility and independence. NPWT can enhance the quality of life for these patients by expediting wound closure and reducing pain. As a result, patients can regain their mobility and independence more quickly.

Emerging Markets

The Global Negative Pressure Wound Therapy (NPWT) market has been witnessing remarkable growth, driven by several factors, including advancements in medical technology and increased awareness about the benefits of NPWT. One noteworthy contributor to this growth is the burgeoning presence of emerging markets. These regions, characterized by rapid economic development and an expanding healthcare infrastructure, hold immense potential to propel the NPWT market to new heights. Emerging markets, often found in developing countries, are characterized by dynamic economic growth, increasing healthcare expenditures, and a growing middle-class population. These markets are witnessing a transformation in healthcare delivery, with improved access to advanced medical treatments and technologies. As a result, they offer a promising landscape for healthcare-related industries, including the NPWT market. Emerging markets are experiencing a surge in chronic diseases, such as diabetes, obesity, and cardiovascular disorders. These conditions are associated with a higher risk of non-healing wounds, making NPWT a vital tool in wound management and accelerating healing. As the prevalence of these diseases increases, so does the demand for NPWT. Emerging markets are witnessing a rise in surgical procedures, driven by factors such as increased healthcare spending, the adoption of modern medical practices, and a growing aging population. Surgical wounds often benefit from NPWT, leading to a higher demand for this technology. Emerging markets are investing heavily in expanding their healthcare infrastructure, including the establishment of modern hospitals and clinics. With a growing number of healthcare facilities, there is a greater opportunity for the adoption of NPWT technology. As healthcare literacy improves in emerging markets, both healthcare professionals and patients become more aware of advanced wound care solutions like NPWT. This increased awareness drives demand and adoption rates. NPWT, although initially considered expensive, can be a cost-effective solution in the long run, especially in emerging markets where the cost of hospital stays, and post-operative care can be high. This cost-effectiveness is encouraging healthcare providers and policymakers to embrace NPWT.

Rise in Chronic Diseases

The Global Negative Pressure Wound Therapy (NPWT) market is experiencing remarkable growth, and one of the key drivers behind this expansion is the alarming increase in chronic diseases worldwide. These conditions, which include diabetes, obesity, cardiovascular diseases, and more, often lead to chronic wounds that require sophisticated wound care solutions like NPWT. Chronic diseases have reached epidemic proportions globally, posing a significant public health challenge. The World Health Organization (WHO) reports that chronic diseases account for approximately 71% of all global deaths, making them the leading cause of mortality worldwide. This alarming trend is driven by several factors, including sedentary lifestyles, poor dietary choices, aging populations, and genetic predisposition. Chronic diseases, particularly diabetes and peripheral vascular diseases, often lead to chronic wounds. These wounds are slow to heal and prone to complications, such as infections and tissue necrosis. NPWT has emerged as an invaluable tool for managing these wounds effectively. NPWT promotes wound healing by creating a controlled environment that stimulates blood flow, reduces edema, and removes excess fluids. For patients with chronic wounds, NPWT can significantly accelerate the healing process and improve overall outcomes. Patients with chronic wounds are at higher risk of infections and other complications, which can lead to prolonged hospital stays and increased healthcare costs. NPWT can mitigate these risks, making it a cost-effective solution in the long run. Diabetic patients are particularly prone to foot ulcers, a common complication of diabetes. NPWT has demonstrated its effectiveness in managing diabetic foot ulcers, which are notorious for their slow healing and potential for amputation. As the number of individuals affected by chronic diseases continues to rise, so does the pool of potential NPWT patients. This expansion of the patient base is a significant driver of market growth.

Surgical Procedures

The Global Negative Pressure Wound Therapy (NPWT) market has been experiencing substantial growth, and one of the driving forces behind this expansion is the continuous evolution of surgical procedures. As surgical techniques become more advanced and widespread, the demand for innovative wound care solutions like NPWT is on the rise. Negative Pressure Wound Therapy, also known as vacuum-assisted closure (VAC) therapy, is a sophisticated medical approach used to expedite wound healing. It involves applying controlled negative pressure to a wound through a vacuum pump connected to a specialized dressing. This process removes excess fluids, stimulates blood flow, and encourages the growth of healthy tissue, leading to improved wound healing outcomes. Modern medicine has seen a surge in complex surgical procedures, including organ transplants, reconstructive surgeries, and bariatric surgeries. These operations often result in larger surgical wounds that require specialized wound care solutions like NPWT for optimal healing. Minimally invasive surgical techniques have gained popularity due to their reduced recovery times and minimal scarring. However, even these procedures may necessitate NPWT for optimal healing, especially in cases where larger incisions are made, or complications arise. Trauma and emergency surgeries are on the rise, driven by accidents and unforeseen medical events. NPWT can be a critical tool in managing wound care during emergency procedures, reducing the risk of complications.

Key Market Challenges

High Initial Costs

One of the primary challenges faced by the NPWT market is the relatively high initial costs associated with the technology. The equipment and consumables required for NPWT can be expensive for healthcare facilities, making it a significant investment. Smaller and underfunded healthcare institutions may find it challenging to afford these upfront costs.

Reimbursement Issues

NPWT reimbursement policies and practices can vary greatly between countries and regions. In some areas, healthcare providers struggle with inconsistent reimbursement rates or complicated billing processes. This can create uncertainty and hinder the adoption of NPWT.

Technological Barriers

While NPWT technology has advanced significantly, there is still room for improvement. Smaller, more portable devices are needed to improve patient mobility and comfort. Additionally, ensuring that NPWT systems are user-friendly and can be effectively used by healthcare professionals in various settings is an ongoing challenge.

Global Supply Chain Disruptions

The COVID-19 pandemic underscored the vulnerability of global supply chains. NPWT relies on the timely availability of consumables and equipment, and disruptions in the supply chain can impact patient care. Manufacturers and healthcare facilities need to ensure a robust supply chain to meet demand.

Key Market Trends

Portable and Wearable Devices

One of the most exciting developments in the NPWT market is the emergence of portable and wearable devices. Traditional NPWT systems are often bulky and require patients to remain immobile. However, wearable NPWT devices offer increased mobility and comfort, enabling patients to continue with their daily activities while receiving therapy. These compact, user-friendly devices are expected to revolutionize wound care and enhance patient compliance.

Connected Healthcare Ecosystem

The integration of NPWT systems into connected healthcare ecosystems is another significant trend on the horizon. These smart devices will enable healthcare providers to remotely monitor patients' progress, ensuring that the therapy is administered effectively. Real-time data collection and analysis will enhance decision-making, potentially reducing the risk of complications and improving patient outcomes.

Advanced Dressing Materials

Innovations in dressing materials are set to play a pivotal role in the NPWT market's future. Manufacturers are continuously researching and developing novel materials that can better conform to wound shapes, enhance fluid management, and improve patient comfort. These materials aim to make NPWT more effective and convenient for both patients and healthcare providers.

Bioactive NPWT Solutions

Bioactive NPWT solutions are designed to accelerate wound healing by promoting tissue regeneration and reducing inflammation. These next-generation therapies may incorporate growth factors, antimicrobial agents, and other bioactive substances to enhance the wound healing process. As research in this field progresses, bioactive NPWT may become a standard approach for complex wounds.

Segmental Insights

Product Insights

In 2022, the conventional devices category held the largest share of revenue, primarily attributed to their high cost and growing adoption. These systems necessitate hospital admission and are impractical for homecare use due to their reliance on heavy canisters. The availability of rental options for these devices is projected to boost NPWT utilization in developing nations where purchasing power is limited.

On the other hand, the single-use NPWT devices segment is anticipated to experience a lucrative Compound Annual Growth Rate (CAGR) in the coming years. This is because they find extensive applicability in home care settings, prompting major companies to emphasize enhancing their cost-efficiency. This strategic focus has proven to be an additional advantage for single-use NPWT devices, particularly in developing countries.

Wound Type Insights

Based on the category of Wound Type, the Pressure Ulcers segment emerged as the dominant player in the global market for negative pressure wound therapy in 2022 primarily due to the extended treatment duration required. Patients dealing with pressure ulcers typically need longer hospital stays, resulting in increased healthcare expenses. Another contributing factor to this growth is its emerging application for addressing pressure-related wounds like bedsores.

Conversely, the diabetic foot ulcers segment is expected to experience the most significant CAGR during the forecast period, mainly due to its remarkable success in NPWT treatment and the high prevalence of diabetes. Diabetic foot ulcers represent the most common form of chronic wounds, and NPWT plays a pivotal role in expediting the healing process for such injuries. Other wound categories include arterial ulcers and surgical wounds, among others.

Regional Insights

In 2022, North America claimed the most significant portion of revenue due to the increased healthcare spending and the highly advanced healthcare infrastructure within the region. Consequently, there has been a notable uptick in the adoption of NPWT devices, both in hospital settings and for homecare purposes. Meanwhile, in the Asia Pacific region, a promising CAGR is expected in the upcoming years. This projection primarily stems from the growing occurrence of traumatic incidents like burns, which subsequently fuels the demand for such therapy in this geographical area.

Key Market Players

  • Acelity LP Inc
  • Talley's Group Ltd
  • Smith & Nephew PLC
  • Devon Health Services Inc
  • Molnlycke Health Care AB
  • Medela AG
  • DeRoyal Industries Inc
  • ConvaTec Inc
  • Cardinal Health Inc
  • PAUL HARTMANN AG

Report Scope:

In this report, the Global Negative Pressure Wound Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Negative Pressure Wound Therapy Market, By Product:

  • Conventional NPWT
  • Single-Use NPWT

Negative Pressure Wound Therapy Market, By Wound Type:

  • Diabetic Foot Ulcers
  • Venous Leg Ulcers
  • Pressure Ulcers
  • Burn Wounds
  • Others

Negative Pressure Wound Therapy Market, By End-use:

  • Hospitals
  • Homecare
  • Others

Negative Pressure Wound Therapy Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Negative Pressure Wound Therapy Market.

Available Customizations:

  • Global Negative Pressure Wound Therapy market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Negative Pressure Wound Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Conventional NPWT, Single-Use NPWT)
    • 5.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)
    • 5.2.3. By End-use (Hospitals, Homecare, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Product Market Map
    • 5.3.1. By Product
    • 5.3.2. By Wound Type
    • 5.3.3. By End-use
    • 5.3.4. By Region

6. North America Negative Pressure Wound Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Conventional NPWT, Single-Use NPWT)
    • 6.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)
    • 6.2.3. By End-use (Hospitals, Homecare, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Negative Pressure Wound Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Wound Type
        • 6.3.1.2.3. By End-use
    • 6.3.2. Canada Negative Pressure Wound Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Wound Type
        • 6.3.2.2.3. By End-use
    • 6.3.3. Mexico Negative Pressure Wound Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Wound Type
        • 6.3.3.2.3. By End-use

7. Europe Negative Pressure Wound Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Conventional NPWT, Single-Use NPWT)
    • 7.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)
    • 7.2.3. By End-use (Hospitals, Homecare, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Negative Pressure Wound Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Wound Type
        • 7.3.1.2.3. By End-use
    • 7.3.2. United Kingdom Negative Pressure Wound Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Wound Type
        • 7.3.2.2.3. By End-use
    • 7.3.3. France Negative Pressure Wound Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Wound Type
        • 7.3.3.2.3. By End-use
    • 7.3.4. Italy Negative Pressure Wound Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Wound Type
        • 7.3.4.2.3. By End-use
    • 7.3.5. Spain Negative Pressure Wound Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Wound Type
        • 7.3.5.2.3. By End-use

8. Asia-Pacific Negative Pressure Wound Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Conventional NPWT, Single-Use NPWT)
    • 8.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)
    • 8.2.3. By End-use (Hospitals, Homecare, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Negative Pressure Wound Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Wound Type
        • 8.3.1.2.3. By End-use
    • 8.3.2. Japan Negative Pressure Wound Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Wound Type
        • 8.3.2.2.3. By End-use
    • 8.3.3. India Negative Pressure Wound Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Wound Type
        • 8.3.3.2.3. By End-use
    • 8.3.4. Australia Negative Pressure Wound Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Wound Type
        • 8.3.4.2.3. By End-use
    • 8.3.5. South Korea Negative Pressure Wound Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Wound Type
        • 8.3.5.2.3. By End-use

9. South America Negative Pressure Wound Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Conventional NPWT, Single-Use NPWT)
    • 9.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)
    • 9.2.3. By End-use (Hospitals, Homecare, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Negative Pressure Wound Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Wound Type
        • 9.3.1.2.3. By End-use
    • 9.3.2. Argentina Negative Pressure Wound Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Wound Type
        • 9.3.2.2.3. By End-use
    • 9.3.3. Colombia Negative Pressure Wound Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Wound Type
        • 9.3.3.2.3. By End-use

10. Middle East and Africa Negative Pressure Wound Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Conventional NPWT, Single-Use NPWT)
    • 10.2.2. By Wound Type (Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, Burn Wounds, Others)
    • 10.2.3. By End-use (Hospitals, Homecare, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Negative Pressure Wound Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Wound Type
        • 10.3.1.2.3. By End-use
    • 10.3.2. Saudi Arabia Negative Pressure Wound Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Wound Type
        • 10.3.2.2.3. By End-use
    • 10.3.3. UAE Negative Pressure Wound Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Wound Type
        • 10.3.3.2.3. By End-use
    • 10.3.4. Kuwait Negative Pressure Wound Therapy Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Wound Type
        • 10.3.4.2.3. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
  • 14.6. SWOT Analysis
    • 14.6.1. Acelity LP Inc
    • 14.6.2. Talley's Group Ltd
    • 14.6.3. Smith & Nephew PLC
    • 14.6.4. Devon Health Services Inc
    • 14.6.5. Molnlycke Health Care AB
    • 14.6.6. Medela AG
    • 14.6.7. DeRoyal Industries Inc
    • 14.6.8. ConvaTec Inc
    • 14.6.9. Cardinal Health Inc
    • 14.6.10. PAUL HARTMANN AG

15. Strategic Recommendations

16. About Us & Disclaimer